Musculoskeletal pain in patients with chronic myeloid leukemia after discontinuation of imatinib: a tyrosine kinase inhibitor withdrawal syndrome?

J Clin Oncol. 2014 Sep 1;32(25):2821-3. doi: 10.1200/JCO.2014.55.6910. Epub 2014 Jul 28.

Authors

Affiliations

¹ Skåne University Hospital, Lund, Sweden [email protected].
² University Hospital, Uppsala, Sweden.
³ Skåne University Hospital, Lund, Sweden.
⁴ University Hospital, Linköping, Sweden.
⁵ University Hospital, Umeå, Sweden.
⁶ Umeå University, Umeå, Sweden.
⁷ Universitätsmedizin Mannheim, Mannheim, Germany.
⁸ Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.

PMID: 25071107
DOI: 10.1200/JCO.2014.55.6910

No abstract available

Publication types

Letter
Kommentar

MeSH terms

Antineoplastic Agents / administration & dosage*
Benzamides / administration & dosage*
Female
Fusion Proteins, bcr-abl / antagonists & inhibitors*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
Male
Piperazines / administration & dosage*
Protein Kinase Inhibitors / administration & dosage*
Pyrimidines / administration & dosage*

Substances

Antineoplastic Agents
Benzamides
Piperazines
Protein Kinase Inhibitors
Pyrimidines
Fusion Proteins, bcr-abl